Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal bupivacaine concentration and hemodynamic changes during TURP
PACTR202304886237340Not yet recruiting
- Sponsor
- sherif kamal hafez arafa
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bupivacaine in benign prostatic hyperplasia (BPH) (3 arms), sponsored by sherif kamal hafez arafa. Primary endpoints: Time for sensory block to T10 and Motor block characteristics. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on PACTR202304886237340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202304886237340.